Live feed
·
INSIDERFiling
ANI Pharmaceuticals Inc. logo

SVP, HEAD - ESTABLISHED BRANDS Rowland Thomas Andrew was granted 6,021 shares and covered exercise/tax liability with 628 shares, increasing direct ownership by 14% to 43,502 units (SEC Form 4)